Press Releases

Date Title and Summary View
Toggle Summary Positive Recommendation for Marketing Authorization from the European Medicines Agency for its innovative drug – NexoBrid™
NexoBrid™ has shown statistically significant effect in earlier eschar removal from burn wounds and reduction in the number and extent of surgical excision and autografting